This tender seeks suppliers for upstream cell culture hardware to support vaccine development in South Africa. Key requirements include high-quality equipment delivery to multiple beneficiaries by February 2026.
The Medical Research Council of South Africa is inviting tenders for the supply and delivery of upstream cell culture hardware as part of a significant project aimed at enhancing vaccine development and production capabilities in South Africa. This initiative, supported by the DSTI/KfW/SAMRC, focuses on equipping multiple beneficiaries with essential hardware that will facilitate advanced scientific research and development in the field of biotechnology.
The scope of this tender includes the provision of state-of-the-art upstream cell culture systems, which are critical for the cultivation of cells used in vaccine production. Suppliers are expected to deliver high-quality equipment that meets stringent scientific standards, ensuring reliability and efficiency in laboratory settings. The successful bidder will need to demonstrate their capability to meet delivery timelines and provide ongoing support for the hardware supplied. This project not only aims to bolster local vaccine production but also contributes to the broader goal of enhancing public health in South Africa.
This tender is suitable for businesses specializing in the supply of scientific research equipment, particularly those with experience in biotechnology and cell culture systems. Companies that can provide high-quality products and reliable support services are encouraged to apply.